AAAAAA
Results: 1-25/56
Authors:
TAYLOR PJ
JONES CE
MARTIN PT
LYNCH SV
JOHNSON AG
POND SM
Citation: Pj. Taylor et al., MICROSCALE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ELECTROSPRAY TANDEMMASS-SPECTROMETRY ASSAY FOR CYCLOSPORINE-A IN BLOOD, Journal of chromatography B. Biomedical sciences and applications, 705(2), 1998, pp. 289-294
Authors:
EYLES DW
MCGRATH JJ
STEDMAN TJ
POND SM
Citation: Dw. Eyles et al., CHIRALITY OF REDUCED HALOPERIDOL IN HUMANS, European neuropsychopharmacology, 8(2), 1998, pp. 127-129
Authors:
MCCANN SJ
LECOUTEUR DG
GREEN AC
BRAYNE C
JOHNSON AG
CHAN D
MCMANUS ME
POND SM
Citation: Sj. Mccann et al., THE EPIDEMIOLOGY OF PARKINSONS-DISEASE IN AN AUSTRALIAN POPULATION, Neuroepidemiology, 17(6), 1998, pp. 310-317
Authors:
BRYANLLUKA LJ
SIEBERT GA
POND SM
Citation: Lj. Bryanlluka et al., METABOLITES OF HALOPERIDOL (HP) INHIBIT THE TRANSPORTERS FOR NORADRENALLNE (NA), DOPAMINE (DA) AND SEROTONIN (5-HT), Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 354-354
Authors:
DODDS HM
TAYLOR PJ
JOHNSON LP
MORTIMER RH
POND SM
CANNELL GR
Citation: Hm. Dodds et al., CORTISOL METABOLISM AND ITS INHIBITION BY GLYCYRRHETINIC ACID IN THE ISOLATED-PERFUSED HUMAN PLACENTAL LOBULE, Journal of steroid biochemistry and molecular biology, 62(4), 1997, pp. 337-343
Authors:
LECOUTEUR DG
LEIGHTON PW
MCCANN SJ
POND SM
Citation: Dg. Lecouteur et al., ASSOCIATION OF A POLYMORPHISM IN THE DOPAMINE-TRANSPORTER GENE WITH PARKINSONS-DISEASE, Movement disorders, 12(5), 1997, pp. 760-763
Authors:
SALM P
TAYLOR PJ
CLARK A
BALDERSON GA
GRYGOTIS A
NORRIS RLG
LYNCH SV
SHAW LM
POND SM
Citation: P. Salm et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY AS A REFERENCE FOR ANALYSIS OF TACROLIMUS TO ASSESS 2 IMMUNOASSAYS IN PATIENTS WITH LIVER AND RENAL-TRANSPLANTS, Therapeutic drug monitoring, 19(6), 1997, pp. 694-700
Authors:
LEIGHTON PW
LECOUTEUR DG
PANG CCP
MCCANN SJ
CHAN D
LAW LK
KAY R
POND SM
WOO J
Citation: Pw. Leighton et al., THE DOPAMINE TRANSPORTER GENE AND PARKINSONS-DISEASE IN A CHINESE POPULATION, Neurology, 49(6), 1997, pp. 1577-1579
Authors:
MIENIE LJ
BERGH JJ
VANSTADEN E
STEYN SJ
POND SM
CASTAGNOLI N
VANDERSCHYF CJ
Citation: Lj. Mienie et al., METABOLIC DEFECTS CAUSED BY TREATMENT WITH THE TETRAHYDROPYRIDINE ANALOG OF HALOPERIDOL (HPTP), IN BABOONS, Life sciences, 61(3), 1997, pp. 265-272
Authors:
AVENT KM
RIKER RR
FRASER GL
VANDERSCHYF CJ
USUKI E
POND SM
Citation: Km. Avent et al., METABOLISM OF HALOPERIDOL TO PYRIDINIUM SPECIES IN PATIENTS RECEIVINGHIGH-DOSES INTRAVENOUSLY - IS HPTP AN INTERMEDIATE, Life sciences, 61(24), 1997, pp. 2383-2390
Authors:
EYLES DW
AVENT KM
STEDMAN TJ
POND SM
Citation: Dw. Eyles et al., 2 PYRIDINIUM METABOLITES OF HALOPERIDOL ARE PRESENT IN THE BRAIN OF PATIENTS AT POSTMORTEM, Life sciences, 60(8), 1997, pp. 529-534
Authors:
MCCANN SJ
POND SM
JAMES KM
LECOUTEUR DG
Citation: Sj. Mccann et al., THE ASSOCIATION BETWEEN POLYMORPHISMS IN THE CYTOCHROME-P-450 2D6 GENE AND PARKINSONS-DISEASE - A CASE-CONTROL STUDY AND METAANALYSIS, Journal of the neurological sciences, 153(1), 1997, pp. 50-53
Authors:
BOWLES MR
MULHERN TD
GORDON RB
INGLIS HR
SHARPE IA
COGILL JL
POND SM
Citation: Mr. Bowles et al., BOUND TRIS CONFOUNDS THE IDENTIFICATION OF BINDING-SITE RESIDUES IN APARAQUAT SINGLE-CHAIN ANTIBODY, Journal of Biochemistry, 122(1), 1997, pp. 101-108
Authors:
TAYLOR PJ
HOGAN NS
LYNCH SV
JOHNSON AG
POND SM
Citation: Pj. Taylor et al., IMPROVED THERAPEUTIC DRUG-MONITORING OF TACROLIMUS (FK506) BY TANDEM MASS-SPECTROMETRY, Clinical chemistry, 43(11), 1997, pp. 2189-2190
Authors:
DODDS HM
TAYLOR PJ
CANNELL GR
POND SM
Citation: Hm. Dodds et al., A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ELECTROSPRAY TANDEM MASS-SPECTROMETRY ANALYSIS OF CORTISOL AND METABOLITES IN PLACENTAL PERFUSATE, Analytical biochemistry, 247(2), 1997, pp. 342-347
Authors:
BOWLES MR
HALL DR
POND SM
WINZOR DJ
Citation: Mr. Bowles et al., STUDIES OF PROTEIN INTERACTIONS BY BIOSENSOR TECHNOLOGY - AN ALTERNATIVE APPROACH TO THE ANALYSIS OF SENSORGRAMS DEVIATING FROM PSEUDO-FIRST-ORDER KINETIC-BEHAVIOR, Analytical biochemistry, 244(1), 1997, pp. 133-143
Authors:
EYLES DW
MCGRATH JJ
POND SM
Citation: Dw. Eyles et al., FORMATION OF PYRIDINIUM SPECIES OF HALOPERIDOL IN HUMAN LIVER AND BRAIN, Psychopharmacology, 125(3), 1996, pp. 214-219
Authors:
LECOUTEUR DG
RIVORY LP
POND SM
Citation: Dg. Lecouteur et al., THE EFFECT OF OXIDATIVE INJURY ON HEPATOCELLULAR INFLUX OF LEUCINE INTHE RAT, HEPATOLOGY RESEARCH, 4(6), 1996, pp. 343-350
Authors:
POND SM
Citation: Sm. Pond, PROFITING FROM VEGETABLES - EDITORIAL COMMENTARY, Journal of toxicology. Clinical toxicology, 34(1), 1996, pp. 9-11
Authors:
RIVORY LP
AVENT KM
POND SM
Citation: Lp. Rivory et al., EFFECTS OF LIPOPHILICITY AND PROTEIN-BINDING ON THE HEPATOCELLULAR UPTAKE AND HEPATIC DISPOSITION OF 2 ANTHRACYCLINES, DOXORUBICIN AND IODODOXORUBICIN, Cancer chemotherapy and pharmacology, 38(5), 1996, pp. 439-445
Authors:
POND SM
Citation: Sm. Pond, ILLUMINATION OF THERAPEUTICS BY TOXICOLOGY - A PERSONAL VIEW, Clinical and experimental pharmacology and physiology, 23(10-11), 1996, pp. 1010-1013
Authors:
VANDERSCHYF CJ
DORMEHL IC
OLIVER DW
HUGO N
KEEVE R
MULLERGARTNER HW
POND SM
CASTAGNOLI N
Citation: Cj. Vanderschyf et al., LONG-TERM TREATMENT WITH THE TETRAHYDROPYRIDINE ANALOG (HPTP) OF HALOPERIDOL INFLUENCES DOPAMINE LIGAND-BINDING IN BABOON BRAIN - AN [I-123] IODOBENZAMIDE (IBZM) SPECT STUDY, Molecular brain research, 43(1-2), 1996, pp. 251-258
Authors:
DODDS HM
WALPOLE ET
RIVORY LP
STRONG RW
POND SM
Citation: Hm. Dodds et al., DISPOSITION OF EPIRUBICIN AFTER INTRAARTERIAL ADMINISTRATION IN LIPIODOL TO PATIENTS WITH HEPATOCELLULAR-CARCINOMA, Therapeutic drug monitoring, 18(5), 1996, pp. 537-543
Authors:
AVENT KM
USUKI E
EYLES DW
KEEVE R
VANDERSCHYF CJ
CASTAGNOLI N
POND SM
Citation: Km. Avent et al., HALOPERIDOL AND ITS TETRAHYDROPYRIDINE DERIVATIVE (HPTP) ARE METABOLIZED TO POTENTIALLY NEUROTOXIC PYRIDINIUM SPECIES IN THE BABOON, Life sciences, 59(17), 1996, pp. 1473-1482
Authors:
BRAND L
OLIVER DW
VANDERSCHYF CJ
POND SM
CASTAGNOLI N
Citation: L. Brand et al., DOPAMINE-RECEPTOR BINDING OF UOROPHENYL)-4-OXOBUTYL]-1,2,3,6-TETRAHYDROPYRIDINE (HPTP), AN INTERMEDIATE METABOLITE OF HALOPERIDOL, Life sciences, 59(10), 1996, pp. 815-820